首页 正文

Circulating tumor DNA (ctDNA)-based minimal residual disease in non-small cell lung cancer

{{output}}
Lung cancer is the second most common cancer worldwide and the leading cause of cancer-related fatalities, with non-small cell lung cancer (NSCLC) accounting for 85% of all lung cancers. Over the past forty years, patients with NSCLC have had a 5-year survival... ...